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Abstract: MYP2 was reported for a candidate locus associated with high grade myopia by 
linkage analysis, but no candidate gene has been detected. We report an association study in the 
Japanese population using 750 microsatellite markers on chromosome 18 that include MYP2 
locus. 450 Japanese subjects with high myopia whose refractive error was greater than or equal 
to –9.25D in at least one eye and equal number of normal control subjects were recruited in this 
study. Three steps screening on the pooled DNA of patients and the pooled DNA of controls 
were performed in this study. A total of 722 microsatellite markers could be analyzed, and we 
obtained 4 positive markers. Then to avoid experimental errors and artifacts, we conﬁ  rmed 
true allele frequency by individual genotyping using initial set of 450 patients and controls. 
Only marker D18S0301i showed statistically signiﬁ  cance, and no marker showed statistically 
signiﬁ  cance on the MYP2 locus. Near the marker D18S0301i, GALNT1 gene was located, but 
its relation to high myopia has remained to be identiﬁ  ed.
Keywords: myopia, MYP2, microsatellite mapping, chromosome18
Introduction
Myopia is a refractive visual disorder often associated with retinal detachment, 
submacular hemorrhage, glaucoma, and macular degeneration (Burton 1989). There-
fore myopia is an important public health problem because it increases the risk of 
visual loss and places a social, economic and health burden on the community. In 
Asian countries including Japan, the prevalence of myopia is very high. For instance, 
in Japan ∼59.3% of the high school students were affected by myopia (Ministry of 
Education, Japan 2004). High grade myopia occupies the high rank of the causes of 
midway blindness for people during their lifespan.
The cause of myopia is unclear, but the importance of environmental factors in the 
prevalence and the progress of the myopia has been well demonstrated by the experiment 
myopia animal models (Wiesel and Raviola 1977; Wallman et al 1978; Hodos et al 1985; 
Raviola and Wiesel 1985; Osol et al 1986; Schaeffel et al 1988; Hung et al 1995). The 
inﬂ  uence of the genetic factors in the development of high myopia has also been demon-
strated in epidemiological studies, such as the family correlated studies and twin studies. 
Although heritability as a measure of estimating the extent to which the genetic factor 
affects the etiology of a particular disease can be easily inﬂ  uenced by the environment, the 
heritability of myopia in the twin studies has shown considerably high values (Hu 1981; 
Teikari et al 1991; Angi et al 1993; Hammond et al 2001; Lyhne et al 2001).
Another measurement that can estimate the extent to which a genetic factor affects 
the etiology of disease is the concept of λR (Risch 1990). Whereas λR is deﬁ  ned as the 
risk ratio for a type R relative of an affected individual compared with the population 
prevalence, λS is a value that divides the proband’s sib’s prevalence of disease with Clinical Ophthalmology 2007:1(3) 312
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the prevalence of disease of the general population. In this 
regard, such analyses have conﬁ  rmed that genetics plays 
an important role in the pathogenesis of high myopia. For 
example, Guggenheim et al (2000), in a Danish epidemio-
logical investigation (Goldschmidt 1968), calculated that 
the λS was 20.0 for high myopia, where the refractive error 
was greater than or equal to −6 diopters(D).
Recent multigenerational linkage studies have reported 
several candidate loci of high myopia, MYP2-MYP5, and 
MYP11-MYP13 (Young, Ronan, Alvear et al 1998; Young, 
Ronan, Drahozal et al 1998; Naiglin et al 2002; Paluru et al 
2003, 2005; Zhang et al 2005, 2006), and several candidate 
loci of myopia, MYP6-MYP10 ( Stambolian et al 2004; 
Hammond et al 2004) on different chromosomes. Among 
them, we focused on the MYP2 locus on chromosome 18 
that showed the highest maximum lod score (9.59). Previ-
ous studies reported that the MYP2 locus was the candidate 
locus of the nonsyndromic autosomal dominant high myo-
pia although these mapping resolution were insufﬁ  cient.
In this study, to clarify the susceptibility genes on chromo-
some 18 related to the appearance of high myopia, we performed 
high resolution mapping by association study using 750 polymor-
phic microsatellite markers distributed across chromosome 18.
Materials and methods
A total of 450 Japanese patients with high myopia whose 
refractive error was greater than or equal to −9.25D in at 
least one eye were recruited in the Hospital of Yokohama 
City University and Okada Eye Clinic. Equal numbers of 
control subjects were recruited at the Tokai University, 
Isehara campus. All the patients with high myopia were 
examined clinically by experienced ophthalmologists, and 
none of the patients were found to have eye diseases, such as 
Marfan syndrome, Stickler syndrome, juvenile glaucoma and 
keratoconus. Control subjects were selected from the general 
population. The average age was 37.8 ± 11.77 years in the 
patient population and the gender ratio was 1.0:1.4 (male: 
female). In the control population, average age was 41.2 ±   
11.67 years and gender ratio was 1.0:1.2 (male: female). 
The average spherical refractive error for patients was OD: 
−11.63 ± 2.21D (range −6.75 to −22.75D), OS: −11.58 ± 
2.21D (range −7.25 to −22.50D). The average axial length 
was OD: 27.78 ± 1.31 mm(range 20.31 to 33.14 mm), OS: 
27.79 ± 1.33 mm(range 23.99 to 34.74 mm). The average 
corneal refraction was OD: 43.94 ± 1.60D (range 39.50 to 
50.25D), OS: 43.94 ± 1.62D (range 39.75 to 53.00D).
Peripheral blood cells were collected and consent to 
genetic screening was obtained from patients and control 
subjects after the details of this study were explained to every 
subject. All patients and healthy control subjects agreed to a 
blood examination conducted according to the guidelines of 
the Declaration of Helsinki.
Based on the knowledge that the average length of linkage 
disquilibrium (LD) is about 100 kb (Tamiya et al 2005), we per-
formed high resolution screening on chromosome 18, including 
the MYP2 locus, using 750 microsatellite markers. The average 
interval length between the markers was 126.8 kb. Information 
on the microsatellites markers was obtained from the JBIRC 
website (Japan Biological Information Research Center).
In order to reduce the cost of genotyping and the total number 
of genotyping assays and associated costs, we performed three 
screens on the pooled DNA of patients and the pooled DNA of the 
controls, separately (Sham et al 2002). The three-step screening 
protocol, as previously described (Tamiya et al 2005), helped to 
decrease the number of false positives. We used 150 myopia indi-
viduals and 150 controls at each step of the screening protocol to 
construct the pooled DNA samples. The frequency of the alleles 
in the pooled DNA were calculated by obtaining the sum total 
of the height of all peak patterns after an electrophoresis run by 
ABI 3700 DNA analyzer (Applied Biosystems) and calculating 
the ratio of the height of each peak.
In the ﬁ  rst screening step, 750 microsatellite markers were 
analyzed using pooled DNA. In the second screening step, only 
the positive markers from the ﬁ  rst screening with statistical 
signiﬁ  cance of p  0.05 by the Fisher’s exact test, either for 
the 2 × 2 or 2 × m contingency table (m refers to the number 
of allele), were genotyped using the pooled DNA that was con-
structed from another 150 myopia individuals and 150 controls. 
Only positive markers showing signiﬁ  cance with p < 0.05 in the 
second screening step were then subjected to the third screening 
step. In this way, the three step screening method could eliminate 
false positives resulting from type 1 errors.
Finally, in order to further exclude experimental errors 
and artifacts, we selected priority microsatellite markers 
based on statistical p-value and peak pattern to conﬁ  rm true 
allele frequency by individual genotyping using the DNA 
samples of the initial set of 450 high myopia individuals and 
450 control individuals.
DNA was extracted by using the QIAamp DNA blood kit 
(QIAGEN) and the DNA concentration was measured using 
the PicoGreen ﬂ  uorescence assay. Because accurate DNA 
concentration was very important in the use of the pooled 
DNA method, measurements were performed in triplicate.
All microsatellite marker speciﬁ  c PCR primers were 
designed to have an annealing temperature of 57 °C, and 
forward primers were labeled with ﬂ  uorogenic probe.Clinical Ophthalmology 2007:1(3) 313
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The volume of the PCR mixture for pooled DNA typing 
was a total of 20 μl containing 24 ng of pooled DNA, 0.5 
units of AmpliTaq-Gold DNA polymerase (Applied Bio-
systems), 5.0 mM dNTPs, 20 μM of each primers and 1X 
reaction buffer. The PCR mixture for individual typing was 
a total of 20 μl containing 8 ng of genomic DNA, 0.5 units of 
AmpliTaq Gold DNA polymerase(Applied Biosystems), 4.0 
mM dNTPs, 1X reaction buffer, 20 μM of each primers and 
1X reaction buffer. The ampliﬁ  cation reactions were carried 
out in GeneAmp PCR system 9700 (Applied Biosystems) 
with an initial denaturation at 96 °C for 5 min (hot start), 
annealing at 57 °C for 1 min, and extension at 72 °C for 1 
min and then 40 cycles for three steps of PCR (denaturation 
at 96 °C for 45 s, and annealing at 57 °C for 45 s, and exten-
sion at 72 °C for 1 min).
The quality of the pooled DNA was conﬁ  rmed by compar-
ing the result of allelic distributions between pooled DNA 
typing and individual typing using 6 microsatellite markers 
that had no association with high myopia. Both pooled DNA 
typing and individual typing were carried out using the ABI 
3700 DNA analyzer (Applied Biosystems).
Results
Of the 722 microsatellite markers analyzed in the ﬁ  rst screen-
ing step, 94 markers were calculated to be positive markers 
(Figure 1). Four of the 94 markers were excluded for the 
second screening step because they could not be ampliﬁ  ed, 
or had a very weak peak pattern.
Therefore, in the second screening step, 90 positive mark-
ers from the ﬁ  rst screening were analyzed and only 16 of 
them were found to be positive for subsequent use in a third 
screening. In the third screening, we obtained only 4 positive 
markers (D18S0356i, D18S0201i, D18S0301i, D18S0357i) 
with statistical signiﬁ  cance of p < 0.05 by Fisher’s exact test 
(Table 1).
To exclude experimental errors, we then checked again 
all the peak patterns of the 4 positive markers, and ﬁ  nally 
selected the three markers, D18S0356i, D18S0201i and 
D18S0301i, for further analysis by individual genotyp-
ing in patients and controls. The marker, D18S0357i, was 
excluded from the list for individual typing, because the 
results were not consistent for each step of the screening 
protocol and a variability of certain, peak patterns between 
the three steps.
Table 2 shows the result of individual typing for the three 
selected markers. Only marker D18S0301i that was located 
at 18q12.2, showed statistically signiﬁ  cance (p = 0.038 2 × 
2, OR = 0.61, 95% CI = 0.383 to 0.973) at the allele which 
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Table 2 Statistical signiﬁ  cance of alleles associated with high myopia on chromosome 18
Registration ID  No. of alleles  Allele  Allele frequencies      p-values  OR  95%CI
   amplicon  size  Patient  Control     
D18S0356i 7  431  0.040  0.032    0.4486   
   435  0.006  0.002    0.4522   
   439  0.324  0.333    0.7246   
   443  0.376  0.412    0.1335   
   447  0.219  0.188    0.1127   
   451  0.034  0.031    0.8939   
   455  0.001  0.001    1   
D18S0201i 10  401  0.017  0.017    1   
   427  0.000  0.002    0.4997   
   429  0.010  0.003    0.0894   
   431  0.351  0.379    0.231   
   433  0.069  0.051    0.1274   
   435  0.271  0.272    0.9569   
   437  0.207  0.186    0.3036   
   439  0.045  0.043    0.815   
   441  0.028  0.041    0.1482   
   443  0.001  0.005    0.3743   
D18S0301i 4  458  0.000  0.001    0.4994
   461  0.033  0.054    0.0376  0.61  0.383–0.973
   464  0.962  0.943    0.0596   
   467  0.004  0.002    0.687   
p values were calculated by Fisher’s exact test, based on 2 × 2 contingency tables.
Figure 1 Shows p values by Fisher’s exact test based on 2 × 2 contingency tables 
(Red circles) or on 2 × m contingency tables (Blue circles) in the ﬁ  rst screening.
Blue line indicate p values = 0.05.
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has amplicon size 461. The marker D18S0201i, that was 
located in the MYP2 locus between D18S59 and D18S1146, 
showed no statistically signiﬁ  cance.
Discussion
MYP2 is a candidate locus of the nonsyndromic autosomal 
dominant high myopia ﬁ  rst identiﬁ  ed by Young, Ronan, 
Drahozal et al (1998) who performed a genome-wide linkage 
analysis for myopia susceptibility loci in 8 multigenerational 
families with an autosomal dominant mode of myopia of more 
than −6.00 diopters, and showed a signiﬁ  cant linkage to 18p. 
The maximum lod score was 9.59, with marker D18S481. 
Haplotype analysis further reﬁ  ned this myopia locus to a 
7.6-cM interval between markers D18S59 and D18S1138 
on 18p11.31. Afterwards Young et al (2001) narrowed the 
candidate region to the interval of 0.8 cM between markers 
D18S63 and D18S52. In this region, there are many possible 
candidate genes, such as adenylate cyclase-activating poly-
peptide, thymidylate synthetase, protein tyrosine phosphatase 
receptor, α subunit of guanine nucleotide-binding protein, 
protein tyrosine phosphatase, Niemann-Pick disease protein, 
and the α subunit of laminin.
The transforming growth factor-β-induced factor (TGIF) 
which was mapped to the MYP2 region on 18p11.3, also Clinical Ophthalmology 2007:1(3) 315
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emerged as a candidate gene for high myopia. Subsequently, 
Lam et al (2003) investigated the coding exons of TGIF for 
mutations in Chinese subjects with high myopia, and only 657 
(T-G) showed statistical signiﬁ  cance in the logistic regression 
model (odds ratio 0.133; 95% CI 0.036−0.488; p = 0.002). 
Although TGIF was suggested as a probable candidate gene 
for high myopia by Lam et al (2003), others showed that TGIF 
has no association with high myopia (Scavello 2004; Hasumi 
2006). In our present high resolution screening study, we used 
a total set of 35 microsatellite markers in the MYP2 locus 
between markers D18S59 to D18S52, and found no associa-
tion between MYP2 and high myopia. Therefore, based on our 
study, we conclude that there is no candidate gene for high 
myopia in the MYP2 region in the Japanese population.
On the other hand, we detected another candidate locus 
for high myopia outside the MYP2 region on chromosome 18. 
The microsatellite marker D18S0301i located in chromo-
somal position q12.2, showed statistical signiﬁ  cance (odds 
ratio 0.61; 95%CI 0.383–0.973; p = 0.038). To avoid false 
negative, we performed no correction for multiple compari-
sons such as Bonferoni’s correction in this study.
The gene closest to this microsatellite marker is, GALNT1 
(UDP-N-acetyl-alpha-D-galactosamine). UDP-N-acetyl-
alpha-D-galactosamine is a N-acetylgalactosaminyltrans-
ferase that transfers an N-acetylgalactosamine to a serine or 
threonine residue in the ﬁ  rst step of O-linked oligosaccharide 
biosynthesis (Takai et al 1997). We considered GALNT1 as 
a new candidate gene, but its relation to myopia is debatable 
because of its metabolic function. There is still a possibility 
that a speciﬁ  c allele or mutation in an unknown gene and near 
to the GALTN1 gene is in linkage disequilibrium with marker 
D18S0301i and has yet to be identiﬁ  ed. Therefore, we may 
need to investigate this locus in more detail in future studies.
Since the accumulation of several multigenic factors may 
contribute to the risk and development of chronic diseases, 
we plan to expand our investigations to other chromosomes 
of the human genome, in order to identify all the disease 
susceptibility alleles or mutations involved with high myopia 
at the genome-wide level.
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